List view / Grid view

Ravi Kalyanaraman (Bristol Myers Squibb)

 

article

Counterfeit classifications using Raman spectroscopy and visible near-infrared (VNIR) hyperspectral imaging

22 December 2021 | By , , ,

Colleagues Jeremy Peters, Brittany Handzo, Shan Xiao, PhD and Ravi Kalyanaraman, PhD from the Forensics and Innovative Technologies (FIT) group within Global Quality Analytical Science and Technology (GQAS&T) at Bristol-Myers Squibb, present two methods of counterfeit drug determination.